Showing results (141-150 of 364) with videos related to
Sort By:
Pageof 37
Reviews of Infectious Diseases|July 1, 1987
Does serum protein binding inhibit tissue penetration of antibiotics?T Bergan, A Engeset, W OlszewskiBritish Journal of Clinical Pharmacology|May 1, 1982
Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin baseK Josefsson, T Bergan, L MagniMethods and Findings in Experimental and Clinical Pharmacology|November 1, 1986
Pharmacokinetic evaluation of cefsulodin in children with and without cystic fibrosis treated for infectious diseasesH Michalsen, T Bergan, R SolbergChemotherapy|January 1, 1986
Pharmacokinetics of co-trimazine (sulphadiazine plus trimethoprim) in geriatric patientsT Bergan, S Allgulander, H FellnerClinical Pharmacokinetics|September 1, 1986
Clinical pharmacokinetics of co-trimazineT Bergan, B Ortengren, D WesterlundChemotherapy|January 1, 1980
Piperacillin in the treatment of urinary tract infectionsS Sander, T Bergan, E FossbergAntimicrobial Agents and Chemotherapy|January 1, 1978
Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillinJ Sjövall, L Magni, T BerganScandinavian Journal of Gastroenterology. Supplement|January 1, 1984
Evaluation of Minitec and API as rapid diagnostic methods for anaerobic bacteriaT Bergan, M Vangdal, A SalvesonScandinavian Journal of Infectious Diseases|January 1, 1975
Temporary skin reactions to penicillins during the acute stage of infectious mononucleosisB M Andersen Lund, T BerganActa Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology|August 1, 1985
Characterization of enterotoxigenic Escherichia coli. Serotypes, enterotoxins, adhesion fimbriae, and the presence of plasmidsO Olsvik, R Solberg, T BerganPageof 37